Genetics of type 2 diabetes—pitfalls and possibilities

Genes

Volumn 6, Issue 1, 2015, Pages 87-123

  Prasad, Rashmi B ^a   Groop, Leif ^a,b  

^a LUND UNIVERSITY DIABETES CENTRE   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Common variants; Genetics; Genome wide association studies; Heritability; Parent of origin; Rare variants; Systems biology; Type 2 diabetes

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; CALPAIN 10; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; INSULIN RECEPTOR SUBSTRATE 1; MELATONIN 1 RECEPTOR; MICRORNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POTASSIUM CHANNEL KCNQ1; TRANSCRIPTION FACTOR 7 LIKE 2; UNTRANSLATED RNA;

ABCC8 GENE; ADRA2A GENE; ARTICLE; CAPN10 GENE; CDKN2A GENE; CDKN2B GENE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GIP GENE; HERITABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRS1 GENE; KCJN11 GENE; KCNQ1 GENE; KLF14 GENE; LATENT AUTOIMMUNE DIABETES IN ADULT; LINKAGE ANALYSIS; MATERNALLY INHERITED DIABETES AND DEAFNESS; MTNR1B GENE; NEWBORN DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY DIABETES MELLITUS; RISK FACTOR; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMS BIOLOGY; TCF7L2 GENE;

EID: 84925347828     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes6010087     Document Type: Article

References (174)

1. Groop, L. Lyssenko, V. Genetics of type 2 diabetes. An overview. Endocrinol. Nutr. 2009, 56 (Suppl. 4), 34–37.
2. Diabetes Atlas, 2014. Available online: www.Idf.Org/diabetesatlas (accessed on 3 March 2014).
3. WHO. WHO report. 2014. Available online: http://www.who.int/gho/publications/world_health_ statistics/en/ (accessed on 3 March 2014).
4. Lyssenko, V. Jonsson, A. Almgren, P. Pulizzi, N. Isomaa, B. Tuomi, T. Berglund, G. Altshuler, D. Nilsson, P. Groop, L. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N. Engl. J. Med. 2008, 359, 2220–2232.
5. Groop, L. Pathogenesis of type 2 diabetes: The relative contribution of insulin resistance and impaired insulin secretion. Int. J. Clin. Pract. Suppl. 2000, 113, 3–13.
6. Steck, A.K. Rewers, M.J. Genetics of type 1 diabetes. Clin. Chem. 2011, 57, 176–185.
7. Huber, A. Menconi, F. Corathers, S. Jacobson, E.M. Tomer, Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: From epidemiology to mechanisms. Endocr. Rev. 2008, 29, 697–725.
8. Cernea, S. Dobreanu, M. Raz, I. Prevention of type 1 diabetes: Today and tomorrow. Diabetes/Metab. Res. Rev. 2010, 26, 602–605.
9. Kyvik, K.O. Green, A. Beck-Nielsen, H. Concordance rates of insulin dependent diabetes mellitus: A population based study of young Danish twins. BMJ 1995, 311, 913–917.
10. Pociot, F. Norgaard, K. Hobolth, N. Andersen, O. Nerup, J. A nationwide population-based study of the familial aggregation of type 1 (insulin-dependent) diabetes mellitus in Denmark. Danish study group of diabetes in childhood. Diabetologia 1993, 36, 870–875.
11. Polychronakos, C. Li, Q. Understanding type 1 diabetes through genetics: Advances and prospects. Nat. Rev. Genet. 2011, 12, 781–792.
12. Hakonarson, H., Grant, S.F. Genome-wide association studies (GWAS): Impact on elucidating the aetiology of diabetes. Diabetes/Metab. Res. Rev. 2011, 27, 685–696.
13. Groop, L. Pociot, F. Genetics of diabetes—Are we missing the genes or the disease? Mol. Cell. Endocrinol. 2014, 382, 726–739.
14. Stankov, K. Benc, D. Draskovic, D. Genetic and epigenetic factors in etiology of diabetes mellitus type 1. Pediatrics 2013, 132, 1112–1122.
15. Forlenza, G.P. Rewers, M. The epidemic of type 1 diabetes: What is it telling us? Curr. Opin. Endocrinol. Diabetes Obes. 2011, 18, 248–251.
16. Sugihara, S. Genetic susceptibility of childhood type 1 diabetes mellitus in Japan. Pediatr. Endocrinol. Rev. 2012, 10 (Suppl. 1), 62–71.
17. Thomas, I.H. Pietropaolo, M. Type 1 diabetes: A genetic pandora’s box? Pediatr. Diabetes 2010, 11, 511–512.
18. Groop, L. Tuomi, T. Rowley, M. Zimmet, P. Mackay, I.R. Latent autoimmune diabetes in adults (LADA)—More than a name. Diabetologia 2006, 49, 1996–1998.
19. Tuomi, W.V., Kazlauskas, R.J. Molecular basis for enantioselectivity of lipase from pseudomonas cepacia toward primary alcohols. Modeling, kinetics, and chemical modification of tyr29 to increase or decrease enantioselectivity. J. Organ. Chem. 1999, 64, 2638–2647.
20. Tuomi, T. Zimmet, P.Z. Rowley, M.J. Serjeantson, S.W. Mackay, I.R. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy. Diabetologia 1993, 36, 685.
21. Tuomi, T. Santoro, N. Caprio, S. Cai, M. Weng, J. Groop, L. The many faces of diabetes: A disease with increasing heterogeneity. Lancet 2014, 383, 1084–1094.
22. Tuomi, T. Santoro, N. Caprio, S. Cai, M. Weng, J. Groop, L. The many faces of diabetes: A disease with increasing heterogeneity. Lancet 2014, 383, 1084–1094.
23. Carlsson, S., Midthjell, K., Grill, V. Influence of family history of diabetes on incidence and prevalence of latent autoimmune diabetes of the adult: Results from the nord-trondelag health study. Diabetes Care 2007, 30, 3040–3045.
24. Tattersall, R.B. Mild familial diabetes with dominant inheritance. Q. J. Med. 1974, 43, 339–357.
25. Voight, B.F. Scott, L.J. Steinthorsdottir, V. Morris, A.P. Dina, C. Welch, R.P. Zeggini, E. Huth, C. Aulchenko, Y.S. Thorleifsson, G. et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 2010, 42, 579–589.
26. Scott, R.A. Lagou, V. Welch, R.P. Wheeler, E. Montasser, M.E. Luan, J. Magi, R. Strawbridge, R.J. Rehnberg, E. Gustafsson, S. et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat. Genet. 2012, 44, 991–1005.
27. Steinthorsdottir, V. Thorleifsson, G. Reynisdottir, I. Benediktsson, R. Jonsdottir, T. Walters, G.B. Styrkarsdottir, U. Gretarsdottir, S. Emilsson, V. Ghosh, S. et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet. 2007, 39, 770–775.
28. Murphy, R. Turnbull, D.M. Walker, M. Hattersley, A.T. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243a>g mitochondrial point mutation. Diabet. Med. 2008, 25, 383–399.
29. Murphy, R. Ellard, S. Hattersley, A.T. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4, 200–213.
30. Van den Ouweland, J.M., Lemkes, H.H., Ruitenbeek, W., Sandkuijl, L.A. de Vijlder, M.F. Struyvenberg, P.A. van de Kamp, J.J.J.A. Maassen, Mutation in mitochondrial tRNA(leu)(uur) gene in a large pedigree with maternally transmitted type ii diabetes mellitus and deafness. Nat. Genet. 1992, 1, 368–371.
31. Pearson, E.R. Flechtner, I. Njolstad, P.R. Malecki, M.T. Flanagan, S.E. Larkin, B. Ashcroft, F.M. Klimes, I. Codner, E. Iotova, V. et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to kir6.2 mutations. N. Engl. J. Med. 2006, 355, 467–477.
32. Watanabe, R.M. Black, M.H. Xiang, A.H. Allayee, H. Lawrence, J.M. Buchanan, T.A. Genetics of gestational diabetes mellitus and type 2 diabetes. Diabetes Care 2007, 30 (Suppl. 2), S134–S140.
33. Shaat, N. Groop, L. Genetics of gestational diabetes mellitus. Curr. Med. Chem. 2007, 14, 569–583.
34. Cho, Y.M. Kim, T.H. Lim, S. Choi, S.H. Shin, H.D. Lee, H.K. Park, K.S. Jang, H.C. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 2009, 52, 253–261.
35. Lauenborg, J. Grarup, N. Damm, P. Borch-Johnsen, K. Jorgensen, T. Pedersen, O. Hansen, T. Common type 2 diabetes risk gene variants associate with gestational diabetes. J. Clin. Endocrinol. Metab. 2009, 94, 145–150.
36. Robitaille, J. Grant, A.M. The genetics of gestational diabetes mellitus: Evidence for relationship with type 2 diabetes mellitus. Genet. Med. 2008, 10, 240–250.
37. O’Sullivan, J.B. Diabetes mellitus after GDM. Diabetes 1991, 40 (Suppl. 2), 131–135.
38. Kim, C. Newton, K.M. Knopp, R.H. Gestational diabetes and the incidence of type 2 diabetes: A systematic review. Diabetes Care 2002, 25, 1862–1868.
39. Young, B.C. Ecker, J.L. Fetal macrosomia and shoulder dystocia in women with gestational diabetes: Risks amenable to treatment? Curr. Diabetes Rep. 2013, 13, 12–18.
40. Group, H.S.C.R., Metzger, B.E., Lowe, L.P., Dyer, A.R., Trimble, E.R., Chaovarindr, U., Coustan, D.R., Hadden, D.R., McCance, D.R., Hod, M. et al. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 2008, 358, 1991–2002.
41. Köbberling, J. Tillil, H. Empirical risk figures for first-degree relatives of non-insulin dependent diabetics. The Genetics of Diabetes Mellitus Academic Press: London, UK, 1982 pp. 201–209.
42. Kaprio, J. Tuomilehto, J. Koskenvuo, M. Romanov, K. Reunanen, A. Eriksson, J. Stengard, J. Kesaniemi, Y.A. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992, 35, 1060–1067.
43. Newman, B. Selby, J.V. King, M.C. Slemenda, C. Fabsitz, R. Friedman, G.D. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 1987, 30, 763–768.
44. Poulsen, P. Kyvik, K.O. Vaag, A. Beck-Nielsen, H. Heritability of type ii (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance—A population-based twin study. Diabetologia 1999, 42, 139–145.
45. Medici, F. Hawa, M. Ianari, A. Pyke, D.A. Leslie, R.D. Concordance rate for type ii diabetes mellitus in monozygotic twins: Actuarial analysis. Diabetologia 1999, 42, 146–150.
46. Meigs, J.B. Cupples, L.A. Wilson, P.W. Parental transmission of type 2 diabetes: The framingham offspring study. Diabetes 2000, 49, 2201–2207.
47. Diamond, J. The double puzzle of diabetes. Nature 2003, 423, 599–602.
48. Horikawa, Y. Oda, N. Cox, N.J. Li, X. Orho-Melander, M. Hara, M. Hinokio, Y. Lindner, T.H. Mashima, H., Schwarz, P.E. et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 2000, 26, 163–175.
49. Duggirala, R. Blangero, J. Almasy, L. Dyer, T.D. Williams, K.L. Leach, R.J. O’Connell, P., Stern, M.P. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am. J. Hum. Genet. 1999, 64, 1127–1140.
50. Reynisdottir, I. Thorleifsson, G. Benediktsson, R. Sigurdsson, G. Emilsson, V. Einarsdottir, A.S. Hjorleifsdottir, E.E. Orlygsdottir, G.T. Bjornsdottir, G.T., Saemundsdottir, J. et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am. J. Hum. Genet. 2003, 73, 323–335.
51. Grant, S.F. Thorleifsson, G. Reynisdottir, I. Benediktsson, R. Manolescu, A. Sainz, J. Helgason, A. Stefansson, H. Emilsson, V., Helgadottir, A. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 2006, 38, 320–323.
52. Tong, Y., Lin, Y., Zhang, Y., Yang, J., Zhang, Y., Liu, H., Zhang, B. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: A large human genome epidemiology (huge) review and meta-analysis. BMC Med. Genet. 2009, 10, e15.
53. Deeb, S.S. Fajas, L. Nemoto, M. Pihlajamaki, J. Mykkanen, L. Kuusisto, J. Laakso, M. Fujimoto, W. Auwerx, J. A pro12ala substitution in ppargamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 1998, 20, 284–287.
54. Hani, E.H. Boutin, P. Durand, E. Inoue, H. Permutt, M.A. Velho, G. Froguel, P. Missense mutations in the pancreatic islet beta cell inwardly rectifying k+ channel gene (kir6.2/bir): A meta-analysis suggests a role in the polygenic basis of type ii diabetes mellitus in Caucasians. Diabetologia 1998, 41, 1511–1515.
55. Gloyn, A.L. Weedon, M.N. Owen, K.R. Turner, M.J. Knight, B.A. Hitman, G. Walker, M. Levy, J.C. Sampson, M., Halford, S. et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell katp channel subunits kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003, 52, 568–572.
56. Hansen, S.K. Nielsen, E.M. Ek, J. Andersen, G. Glumer, C. Carstensen, B. Mouritzen, P. Drivsholm, T. Borch-Johnsen, K., Jorgensen, T. et al. Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes. J. Clin. Endocrinol. Metab. 2005, 90, 3629–3637.
57. Gloyn, A.L. Cummings, E.A. Edghill, E.L. Harries, L.W. Scott, R. Costa, T. Temple, I.K. Hattersley, A.T. Ellard, S. Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel. J. Clin. Endocrinol. Metab. 2004, 89, 3932–3935.
58. Sladek, R. Rocheleau, G. Rung, J. Dina, C. Shen, L. Serre, D. Boutin, P. Vincent, D. Belisle, A., Hadjadj, S. et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445, 881–885.
59. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT Lund University Novartis Institutes of BioMedical Research Saxena, R., Voight, B.F., Lyssenko, V., Burtt, N.P., de Bakker, P.I., Chen, H., Roix, J.J. et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316, 1331–1336.
60. Scott, L.J. Mohlke, K.L. Bonnycastle, L.L. Willer, C.J. Li, Y. Duren, W.L. Erdos, M.R. Stringham, H.M. Chines, P.S., Jackson, A.U. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316, 1341–1345.
61. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 2007, 447, 661–678.
62. Morris, A.P. Voight, B.F. Teslovich, T.M. Ferreira, T. Segre, A.V. Steinthorsdottir, V. Strawbridge, R.J. Khan, H. Grallert, H., Mahajan, A. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 2012, 44, 981–990.
63. Cho, Y.S. Chen, C.H. Hu, C. Long, J. Ong, R.T. Sim, X. Takeuchi, F. Wu, Y. Go, M.J., Yamauchi, T. et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in East Asians. Nat. Genet. 2012, 44, 67–72.
64. Imamura, M. Maeda, S. Yamauchi, T. Hara, K. Yasuda, K. Morizono, T. Takahashi, A. Horikoshi, M. Nakamura, M., Fujita, H. et al. A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations. Hum. Mol. Genet. 2012, 21, 3042–3049.
65. Kooner, J.S. Saleheen, D. Sim, X. Sehmi, J. Zhang, W. Frossard, P. Been, L.F. Chia, K.S. Dimas, A.S., Hassanali, N. et al. Genome-wide association study in individuals of south Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat. Genet. 2011, 43, 984–989.
66. Li, H. Gan, W. Lu, L. Dong, X. Han, X. Hu, C. Yang, Z. Sun, L. Bao, W., Li, P. et al. A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese hans. Diabetes 2013, 62, 291–298.
67. Palmer, N.D. McDonough, C.W. Hicks, P.J. Roh, B.H. Wing, M.R. An, S.S. Hester, J.M. Cooke, J.N. Bostrom, M.A., Rudock, M.E. et al. A genome-wide association search for type 2 diabetes genes in African Americans. PLOS ONE 2012, 7, e29202.
68. Parra, E.J. Below, J.E. Krithika, S. Valladares, A. Barta, J.L. Cox, N.J. Hanis, C.L. Wacher, N. Garcia-Mena, J., Hu, P. et al. Genome-wide association study of type 2 diabetes in a sample from Mexico city and a meta-analysis of a Mexican-American sample from starr county, Texas. Diabetologia 2011, 54, 2038–2046.
69. Shu, X.O. Long, J. Cai, Q. Qi, L. Xiang, Y.B. Cho, Y.S. Tai, E.S. Li, X. Lin, X., Chow, W.H. et al. Identification of new genetic risk variants for type 2 diabetes. PLOS Genet. 2010, 6, e1001127.
70. DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium South Asian Type 2 Diabetes (SAT2D) Consortium Mexican American Type 2 Diabetes (MAT2D) Consortium Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) Consortium Mahajan, A., Go, M.J., Zhang, W., Below, J.E., Gaulton, K.J. et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 2014, 46, 234–244.
71. Yasuda, K. Miyake, K. Horikawa, Y. Hara, K. Osawa, H. Furuta, H. Hirota, Y. Mori, H. Jonsson, A., Sato, Y. et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet. 2008, 40, 1092–1097.
72. Unoki, H. Takahashi, A. Kawaguchi, T. Hara, K. Horikoshi, M. Andersen, G. Ng, D.P. Holmkvist, J. Borch-Johnsen, K., Jorgensen, T. et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat. Genet. 2008, 40, 1098–1102.
73. Yamauchi, T. Hara, K. Maeda, S. Yasuda, K. Takahashi, A. Horikoshi, M. Nakamura, M. Fujita, H. Grarup, N., Cauchi, S. et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat. Genet. 2010, 42, 864–868.
74. Tabassum, R. Chauhan, G. Dwivedi, O.P. Mahajan, A. Jaiswal, A. Kaur, I. Bandesh, K. Singh, T. Mathai, B.J., Pandey, Y. et al. Genome-wide association study for type 2 diabetes in Indians identifies a new susceptibility locus at 2q21. Diabetes 2013, 62, 977–986.
75. Consortium, S.T.D., Williams, A.L., Jacobs, S.B., Moreno-Macias, H., Huerta-Chagoya, A., Churchhouse, C., Marquez-Luna, C., Garcia-Ortiz, H., Gomez-Vazquez, M.J., Burtt, N.P. et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 2014, 506, 97–101.
76. Sun, X. Yu, W. Hu, C. Genetics of type 2 diabetes: Insights into the pathogenesis and its clinical application. BioMed. Res. Int. 2014, 2014, 926713.
77. Li, Y.R., Keating, B.J. Trans-ethnic genome-wide association studies: Advantages and challenges of mapping in diverse populations. Genome Med. 2014, 6, e91.
78. Morris, A.P. Transethnic meta-analysis of genomewide association studies. Genet. Epidemiol. 2011, 35, 809–822.
79. Albrechtsen, A. Grarup, N. Li, Y. Sparso, T. Tian, G. Cao, H. Jiang, T. Kim, S.Y. Korneliussen, T., Li, Q. et al. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia 2013, 56, 298–310.
80. Zeggini, E. Scott, L.J. Saxena, R. Voight, B.F. Marchini, J.L. Hu, T. de Bakker, P.I. Abecasis, G.R. Almgren, P., Andersen, G. et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 2008, 40, 638–645.
81. Dupuis, J. Langenberg, C. Prokopenko, I. Saxena, R. Soranzo, N. Jackson, A.U. Wheeler, E. Glazer, N.L. Bouatia-Naji, N., Gloyn, A.L. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 2010, 42, 105–116.
82. Weedon, M.N. Schwarz, P.E. Horikawa, Y. Iwasaki, N. Illig, T. Holle, R. Rathmann, W. Selisko, T. Schulze, J., Owen, K.R. et al. Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am. J. Hum. Genet. 2003, 73, 1208–1212.
83. Rung, J. Cauchi, S. Albrechtsen, A. Shen, L. Rocheleau, G. Cavalcanti-Proenca, C. Bacot, F. Balkau, B. Belisle, A., Borch-Johnsen, K. et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat. Genet. 2009, 41, 1110–1115.
84. Qi, L. Cornelis, M.C. Kraft, P. Stanya, K.J. Linda Kao, W.H. Pankow, J.S. Dupuis, J. Florez, J.C. Fox, C.S., Pare, G. et al. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum. Mol. Genet. 2010, 19, 2706–2715.
85. Saxena, R. Elbers, C.C. Guo, Y. Peter, I. Gaunt, T.R. Mega, J.L. Lanktree, M.B. Tare, A. Castillo, B.A., Li, Y.R. et al. Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am. J. Hum. Genet. 2012, 90, 410–425.
86. Saxena, R. Hivert, M.F. Langenberg, C. Tanaka, T. Pankow, J.S. Vollenweider, P. Lyssenko, V. Bouatia-Naji, N. Dupuis, J., Jackson, A.U. et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat. Genet. 2010, 42, 142–148.
87. Zeggini, E. Weedon, M.N. Lindgren, C.M. Frayling, T.M. Elliott, K.S. Lango, H. Timpson, N.J. Perry, J.R. Rayner, N.W., Freathy, R.M. et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316, 1336–1341.
88. Thorleifsson, G. Walters, G.B. Gudbjartsson, D.F. Steinthorsdottir, V. Sulem, P. Helgadottir, A. Styrkarsdottir, U. Gretarsdottir, S. Thorlacius, S., Jonsdottir, I. et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 2009, 41, 18–24.
89. Sandhu, M.S. Weedon, M.N. Fawcett, K.A. Wasson, J. Debenham, S.L. Daly, A. Lango, H. Frayling, T.M. Neumann, R.J., Sherva, R. et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat. Genet. 2007, 39, 951–953.
90. Minton, J.A., Hattersley, A.T., Owen, K., McCarthy, M.I., Walker, M., Latif, F., Barrett, T., Frayling, T.M. Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. Populations. Diabetes 2002, 51, 1287–1290.
91. Sim, X. Ong, R.T. Suo, C. Tay, W.T. Liu, J. Ng, D.P. Boehnke, M. Chia, K.S. Wong, T.Y., Seielstad, M. et al. Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from Southeast Asia. PLOS Genet. 2011, 7, e1001363.
92. Takeuchi, F. Serizawa, M. Yamamoto, K. Fujisawa, T. Nakashima, E. Ohnaka, K. Ikegami, H. Sugiyama, T. Katsuya, T., Miyagishi, M. et al. Confirmation of multiple risk loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 2009, 58, 1690–1699.
93. Perry, J.R. Voight, B.F. Yengo, L. Amin, N. Dupuis, J. Ganser, M. Grallert, H. Navarro, P. Li, M., Qi, L. et al. Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. PLOS Genet. 2012, 8, e1002741.
94. Ng, M.C. Shriner, D. Chen, B.H. Li, J. Chen, W.M. Guo, X. Liu, J. Bielinski, S.J. Yanek, L.R., Nalls, M.A. et al. Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes. PLOS Genet. 2014, 10, e1004517.
95. Tsai, F.J. Yang, C.F. Chen, C.C. Chuang, L.M. Lu, C.H. Chang, C.T. Wang, T.Y. Chen, R.H. Shiu, C.F., Liu, Y.M. et al. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLOS Genet. 2010, 6, e1000847.
96. Rosengren, A.H. Jokubka, R. Tojjar, D. Granhall, C. Hansson, O. Li, D.Q. Nagaraj, V. Reinbothe, T.M. Tuncel, J., Eliasson, L. et al. Overexpression of alpha2a-adrenergic receptors contributes to type 2 diabetes. Science 2010, 327, 217–220.
97. Saxena, R. Gianniny, L. Burtt, N.P. Lyssenko, V. Giuducci, C. Sjogren, M. Florez, J.C. Almgren, P. Isomaa, B., Orho-Melander, M. et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006, 55, 2890–2895.
98. Salonen, J.T. Uimari, P. Aalto, J.M. Pirskanen, M. Kaikkonen, J. Todorova, B. Hypponen, J. Korhonen, V.P. Asikainen, J., Devine, C. et al. Type 2 diabetes whole-genome association study in four populations: The diagen consortium. Am. J. Hum. Genet. 2007, 81, 338–345.
99. Timpson, N.J. Lindgren, C.M. Weedon, M.N. Randall, J. Ouwehand, W.H. Strachan, D.P. Rayner, N.W. Walker, M. Hitman, G.A., Doney, A.S. et al. Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Diabetes 2009, 58, 505–510.
100. Strawbridge, R.J. Dupuis, J. Prokopenko, I. Barker, A. Ahlqvist, E. Rybin, D. Petrie, J.R. Travers, M.E. Bouatia-Naji, N., Dimas, A.S. et al. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 2011, 60, 2624–2634.
101. Kong, A. Steinthorsdottir, V. Masson, G. Thorleifsson, G. Sulem, P. Besenbacher, S. Jonasdottir, A. Sigurdsson, A. Kristinsson, K.T., Frigge, M.L. et al. Parental origin of sequence variants associated with complex diseases. Nature 2009, 462, 868–874.
102. Prokopenko, I. Langenberg, C. Florez, J.C. Saxena, R. Soranzo, N. Thorleifsson, G. Loos, R.J. Manning, A.K. Jackson, A.U., Aulchenko, Y. et al. Variants in MTNR1B influence fasting glucose levels. Nat. Genet. 2009, 41, 77–81.
103. Willer, C.J. Sanna, S. Jackson, A.U. Scuteri, A. Bonnycastle, L.L. Clarke, R. Heath, S.C. Timpson, N.J. Najjar, S.S., Stringham, H.M. et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 2008, 40, 161–169.
104. Saxena, R. Saleheen, D. Been, L.F. Garavito, M.L. Braun, T. Bjonnes, A. Young, R. Ho, W.K. Rasheed, A., Frossard, P. et al. Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in sikhs of punjabi origin from India. Diabetes 2013, 62, 1746–1755.
105. Frayling, T.M. Timpson, N.J. Weedon, M.N. Zeggini, E. Freathy, R.M. Lindgren, C.M. Perry, J.R. Elliott, K.S. Lango, H., Rayner, N.W. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316, 889–894.
106. Gudmundsson, J. Sulem, P. Steinthorsdottir, V. Bergthorsson, J.T. Thorleifsson, G. Manolescu, A. Rafnar, T. Gudbjartsson, D. Agnarsson, B.A., Baker, A. et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat. Genet. 2007, 39, 977–983.
107. Winckler, W. Burtt, N.P. Holmkvist, J. Cervin, C. de Bakker, P.I. Sun, M. Almgren, P. Tuomi, T. Gaudet, D., Hudson, T.J. et al. Association of common variation in the hnf1alpha gene region with risk of type 2 diabetes. Diabetes 2005, 54, 2336–2342.
108. Winckler, W. Graham, R.R. de Bakker, P.I. Sun, M. Almgren, P. Tuomi, T. Gaudet, D. Hudson, T.J. Ardlie, K.G., Daly, M.J. et al. Association testing of variants in the hepatocyte nuclear factor 4alpha gene with risk of type 2 diabetes in 7883 people. Diabetes 2005, 54, 886–892.
109. Chambers, J.C. Elliott, P. Zabaneh, D. Zhang, W. Li, Y. Froguel, P. Balding, D. Scott, J. Kooner, J.S. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat. Genet. 2008, 40, 716–718.
110. Manning, A.K. Hivert, M.F. Scott, R.A. Grimsby, J.L. Bouatia-Naji, N. Chen, H. Rybin, D. Liu, C.T. Bielak, L.F., Prokopenko, I. et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat. Genet. 2012, 44, 659–669.
111. Chen, G. Bentley, A. Adeyemo, A. Shriner, D. Zhou, J. Doumatey, A. Huang, H. Ramos, E. Erdos, M., Gerry, N. et al. Genome-wide association study identifies novel loci association with fasting insulin and insulin resistance in African Americans. Hum. Mol. Genet. 2012, 21, 4530–4536.
112. Go, M.J. Hwang, J.Y. Kim, Y.J. Hee Oh, J. Kim, Y.J. Heon Kwak, S. Soo Park, K. Lee, J., Kim, B.J., Han, B.G. et al. New susceptibility loci in myl2, C12orf51 and oas1 associated with 1-h plasma glucose as predisposing risk factors for type 2 diabetes in the Korean population. J. Hum. Genet. 2013, 58, 362–365.
113. Lupski, J.R. Belmont, J.W. Boerwinkle, E. Gibbs, R.A. Clan genomics and the complex architecture of human disease. Cell 2011, 147, 32–43.
114. Manolio, T.A. Collins, F.S. Cox, N.J. Goldstein, D.B. Hindorff, L.A. Hunter, D.J. McCarthy, M.I. Ramos, E.M. Cardon, L.R., Chakravarti, A. et al. Finding the missing heritability of complex diseases. Nature 2009, 461, 747–753.
115. Steinthorsdottir, V. Thorleifsson, G. Sulem, P. Helgason, H. Grarup, N. Sigurdsson, A. Helgadottir, H.T. Johannsdottir, H. Magnusson, O.T., Gudjonsson, S.A. et al. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat. Genet. 2014, 46, 294–298.
116. Moltke, I. Grarup, N. Jorgensen, M.E. Bjerregaard, P. Treebak, J.T. Fumagalli, M. Korneliussen, T.S. Andersen, M.A. Nielsen, T.S., Krarup, N.T. et al. A common greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature 2014, 512, 190–193.
117. Consortium, S.T.D., Estrada, K., Aukrust, I., Bjorkhaug, L., Burtt, N.P., Mercader, J.M., Garcia-Ortiz, H., Huerta-Chagoya, A., Moreno-Macias, H., Walford, G. et al. Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population. JAMA 2014, 311, 2305–2314.
118. Huyghe, J.R. Jackson, A.U. Fogarty, M.P. Buchkovich, M.L. Stancakova, A. Stringham, H.M. Sim, X. Yang, L. Fuchsberger, C., Cederberg, H. et al. Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat. Genet. 2013, 45, 197–201.
119. Flannick, J. Thorleifsson, G. Beer, N.L. Jacobs, S.B. Grarup, N. Burtt, N.P. Mahajan, A. Fuchsberger, C. Atzmon, G., Benediktsson, R. et al. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat. Genet. 2014, 46, 357–363.
120. Wellcome Trust Case Control Consortium Craddock, N., Hurles, M.E., Cardin, N., Pearson, R.D., Plagnol, V., Robson, S., Vukcevic, D., Barnes, C., Conrad, D.F. et al. Genome-wide association study of cnvs in 16,000 cases of eight common diseases and 3000 shared controls. Nature 2010, 464, 713–720.
121. Plomin, R. Haworth, C.M. Davis, O.S. Common disorders are quantitative traits. Nat. Rev. Genet. 2009, 10, 872–878.
122. McClellan, J. King, M.C. Genetic heterogeneity in human disease. Cell 2010, 141, 210–217.
123. Mitchell, K.J. What is complex about complex disorders? Genome Biol. 2012, 13, e237.
124. Agarwala, V. Flannick, J. Sunyaev, S. Go, T.D.C. Altshuler, D. Evaluating empirical bounds on complex disease genetic architecture. Nat. Genet. 2013, 45, 1418–1427.
125. Lyssenko, V. Nagorny, C.L. Erdos, M.R. Wierup, N. Jonsson, A. Spegel, P. Bugliani, M. Saxena, R. Fex, M., Pulizzi, N. et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat. Genet. 2009, 41, 82–88.
126. Bouatia-Naji, N. Bonnefond, A. Cavalcanti-Proenca, C. Sparso, T. Holmkvist, J. Marchand, M. Delplanque, J. Lobbens, S. Rocheleau, G., Durand, E. et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat. Genet. 2009, 41, 89–94.
127. Zhou, Y. Park, S.Y. Su, J. Bailey, K. Ottosson-Laakso, E. Shcherbina, L. Oskolkov, N. Zhang, E. Thevenin, T., Fadista, J. et al. TCF7L2 is a master regulator of insulin production and processing. Hum. Mol. Genet. 2014, 23, 6419–6431.
128. Lyssenko, V. Lupi, R. Marchetti, P. Del Guerra, S. Orho-Melander, M. Almgren, P. Sjogren, M. Ling, C. Eriksson, K.F., Lethagen, A.L. et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J. Clin. Investig. 2007, 117, 2155–2163.
129. Lyssenko, V. Eliasson, L. Kotova, O. Pilgaard, K. Wierup, N. Salehi, A. Wendt, A. Jonsson, A. de Marinis, Y.Z., Berglund, L.M. et al. Pleiotropic effects of gip on islet function involve osteopontin. Diabetes 2011, 60, 2424–2433.
130. Rosengren, A.H. Braun, M. Mahdi, T. Andersson, S.A. Travers, M.E. Shigeto, M. Zhang, E. Almgren, P. Ladenvall, C., Axelsson, A.S. et al. Reduced insulin exocytosis in human pancreatic beta-cells with gene variants linked to type 2 diabetes. Diabetes 2012, 61, 1726–1733.
131. Ingelsson, E. Langenberg, C. Hivert, M.F. Prokopenko, I. Lyssenko, V. Dupuis, J. Magi, R. Sharp, S. Jackson, A.U., Assimes, T.L. et al. Detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans. Diabetes 2010, 59, 1266–1275.
132. Grarup, N., Andersen, G., Krarup, N.T., Albrechtsen, A., Schmitz, O., Jorgensen, T., Borch-Johnsen, K., Hansen, T., Pedersen, O. Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4516 glucose-tolerant middle-aged danes. Diabetes 2008, 57, 2534–2540.
133. Tang, Y., Axelsson, A.S., Spegel, P., Andersson, L.E., Mulder, H., Groop, L.C., Renstrom, E., Rosengren, A.H. Genotype-based treatment of type 2 diabetes with an alpha2a-adrenergic receptor antagonist. Sci. Transl. Med. 2014, 6, 257ra139.
134. Visscher, P.M., Hill, W.G., Wray, N.R. Heritability in the genomics era—Concepts and misconceptions. Nat. Rev. Genet. 2008, 9, 255–266.
135. Lee, S.H., Wray, N.R., Goddard, M.E., Visscher, P.M. Estimating missing heritability for disease from genome-wide association studies. Am. J. Hum. Genet. 2011, 88, 294–305.
136. Yang, J. Benyamin, B. McEvoy, B.P. Gordon, S. Henders, A.K. Nyholt, D.R. Madden, P.A. Heath, A.C. Martin, N.G., Montgomery, G.W. et al. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 2010, 42, 565–569.
137. Visscher, P.M. Yang, J. Goddard, M.E. A commentary on “common SNPs explain a large proportion of the heritability for human height” by yang et al. (2010). Twin Res. Hum. Genet. 2010, 13, 517–524.
138. Groop, L. Forsblom, C. Lehtovirta, M. Tuomi, T. Karanko, S. Nissen, M. Ehrnstrom, B.O. Forsen, B. Isomaa, B., Snickars, B. et al. Metabolic consequences of a family history of niddm (the botnia study): Evidence for sex-specific parental effects. Diabetes 1996, 45, 1585–1593.
139. Hemminki, K. Li, X. Sundquist, K. Sundquist, J. Familial risks for type 2 diabetes in Sweden. Diabetes Care 2010, 33, 293–297.
140. Chong, S. Whitelaw, E. Epigenetic germline inheritance. Curr. Opin. Genet. Dev. 2004, 14, 692–696.
141. Liu, L. Li, Y. Tollefsbol, T.O. Gene-environment interactions and epigenetic basis of human diseases. Curr. Issues Mol. Biol. 2008, 10, 25–36.
142. Small, K.S. Hedman, A.K. Grundberg, E. Nica, A.C. Thorleifsson, G. Kong, A. Thorsteindottir, U. Shin, S.Y. Richards, H.B., Soranzo, N. et al. Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat. Genet. 2011, 43, 561–564.
143. Hanson, R.L. Guo, T. Muller, Y.L. Fleming, J. Knowler, W.C. Kobes, S. Bogardus, C. Baier, L.J. Strong parent-of-origin effects in the association of KCNQ1 variants with type 2 diabetes in American Indians. Diabetes 2013, 62, 2984–2991.
144. Moore, T. Haig, D. Genomic imprinting in mammalian development: A parental tug-of-war. Trends Genet. TIG 1991, 7, 45–49.
145. Wolf, J.B. Hager, R. A maternal-offspring coadaptation theory for the evolution of genomic imprinting. PLOS Biol. 2006, 4, e380.
146. Hales, C.N. Barker, D.J. The thrifty phenotype hypothesis. Br. Med. Bull. 2001, 60, 5–20.
147. Barker, D.J. The origins of the developmental origins theory. J. Intern. Med. 2007, 261, 412–417.
148. Travers, M.E. Mackay, D.J. Dekker Nitert, M. Morris, A.P. Lindgren, C.M. Berry, A. Johnson, P.R. Hanley, N. Groop, L.C. McCarthy, M.I. et al. Insights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets. Diabetes 2013, 62, 987–992.
149. Hoggart, C.J., Venturini, G., Mangino, M., Gomez, F., Ascari, G., Zhao, J.H., Teumer, A., Winkler, T.W., Tsernikova, N., Luan, J. et al. Novel approach identifies SNPs in slc2a10 and kcnk9 with evidence for parent-of-origin effect on body mass index. PLOS Genet. 2014, 10, e1004508.
150. Phillips, P.C. Epistasis—The essential role of gene interactions in the structure and evolution of genetic systems. Nat. Rev. Genet. 2008, 9, 855–867.
151. Cordell, H.J. Wedig, G.C. Jacobs, K.B. Elston, R.C. Multilocus linkage tests based on affected relative pairs. Am. J. Hum. Genet. 2000, 66, 1273–1286.
152. Cox, N.J., Frigge, M., Nicolae, D.L., Concannon, P., Hanis, C.L., Bell, G.I., Kong, A. Loci on chromosomes 2 (niddm1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat. Genet. 1999, 21, 213–215.
153. Gonzalez-Perez, A. Gayan, J. Marin, J. Galan, J.J. Saez, M.E. Real, L.M. Antunez, C. Ruiz, A. Whole-genome conditional two-locus analysis identifies novel candidate genes for late-onset parkinson’s disease. Neurogenetics 2009, 10, 173–181.
154. Nair, R.P. Duffin, K.C. Helms, C. Ding, J. Stuart, P.E. Goldgar, D. Gudjonsson, J.E. Li, Y. Tejasvi, T. Feng, B.J. et al. Genome-wide scan reveals association of psoriasis with il-23 and nf-kappab pathways. Nat. Genet. 2009, 41, 199–204.
155. Evans, D.M. Marchini, J. Morris, A.P. Cardon, L.R. Two-stage two-locus models in genome-wide association. PLOS Genet. 2006, 2, e157.
156. Zuk, O. Hechter, E. Sunyaev, S.R. Lander, E.S. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. USA 2012, 109, 1193–1198.
157. Kato, M. Natarajan, R. Diabetic nephropathy—Emerging epigenetic mechanisms. Nat. Rev. Nephrol. 2014, 10, 517–530.
158. Brasacchio, D. Okabe, J. Tikellis, C. Balcerczyk, A. George, P. Baker, E.K. Calkin, A.C. Brownlee, M. Cooper, M.E. El-Osta, A. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 2009, 58, 1229–1236.
159. Davidson, B.L. McCray, P.B., Jr. Current prospects for RNA interference-based therapies. Nat. Rev. Genet. 2011, 12, 329–340.
160. Fernandez-Valverde, S.L. Taft, R.J. Mattick, J.S. MicroRNAs in beta-cell biology, insulin resistance, diabetes and its complications. Diabetes 2011, 60, 1825–1831.
161. Hariharan, M. Scaria, V. Brahmachari, S.K. Dbsmr: A novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinform. 2009, 10, e108.
162. Broadbent, H.M. Peden, J.F. Lorkowski, S. Goel, A. Ongen, H. Green, F. Clarke, R. Collins, R. Franzosi, M.G. Tognoni, G. et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the anril locus on chromosome 9p. Hum. Mol. Genet. 2008, 17, 806–814.
163. Eftychi, C. Howson, J.M. Barratt, B.J. Vella, A. Payne, F. Smyth, D.J. Twells, R.C. Walker, N.M. Rance, H.E. Tuomilehto-Wolf, E. et al. Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and pparg2 in type 1 diabetes. Diabetes 2004, 53, 870–873.
164. Raj, S.M. Howson, J.M. Walker, N.M. Cooper, J.D. Smyth, D.J. Field, S.F. Stevens, H.E. Todd, J.A. No association of multiple type 2 diabetes loci with type 1 diabetes. Diabetologia 2009, 52, 2109–2116.
165. Andersen, M.K., Sterner, M., Forsen, T., Karajamaki, A., Rolandsson, O., Forsblom, C., Groop, P.H., Lahti, K., Nilsson, P.M., Groop, L. et al. Type 2 diabetes susceptibility gene variants predispose to adult-onset autoimmune diabetes. Diabetologia 2014, 57, 1859–1868.
166. Van Hoek, M. van Herpt, T.W. Dehghan, A. Hofman, A. Lieverse, A.G. van Duijn, C.M. Witteman, J.C. Sijbrands, E.J. Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons. Diabetologia 2011, 54, 1360–1367.
167. Wenzlau, J.M., Juhl, K. Yu, L. Moua, O. Sarkar, S.A. Gottlieb, P.M. Rewers, Eisenbarth, G.S., Jensen, J., Davidson, H.W. et al. The cation efflux transporter znt8 (SLC30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. USA 2007, 104, 17040–17045.
168. Corona, E. Dudley, J.T. Butte, A.J. Extreme evolutionary disparities seen in positive selection across seven complex diseases. PLOS ONE 2010, 5, e12236.
169. Frayling, T.M. Colhoun, H. Florez, J.C. A genetic link between type 2 diabetes and prostate cancer. Diabetologia 2008, 51, 1757–1760.
170. Fadista, J. Vikman, P. Laakso, E.O. Mollet, I.G. Esguerra, J.L. Taneera, J. Storm, P. Osmark, P. Ladenvall, C. Prasad, R.B. et al. Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. Proc. Natl. Acad. Sci. USA 2014, 111, 13924–13929.
171. Suhre, K. Shin, S.Y. Petersen, A.K. Mohney, R.P. Meredith, D. Wagele, B. Altmaier, E. CardioGram Deloukas, P. Erdmann, J. et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 2011, 477, 54–60.
172. Kanehisa, M. Goto, S. Kawashima, S. Okuno, Y. Hattori, M. The kegg resource for deciphering the genome. Nucleic Acids Res. 2004, 32, D277–D280.
173. Taneera, J. Lang, S. Sharma, A. Fadista, J. Zhou, Y. Ahlqvist, E. Jonsson, A. Lyssenko, V. Vikman, P. Hansson, O. et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab. 2012, 16, 122–134.
174. Taneera, J. Fadista, J. Ahlqvist, E. Zhang, M. Wierup, N. Renstrom, E. Groop, L. Expression profiling of cell cycle genes in human pancreatic islets with and without type 2 diabetes. Mol. Cell. Endocrinol. 2013, 375, 35–42.